audio 15:55 min: Implementing Patient-Centered Outcomes in Cancer Trials

audio

oday we are speaking with Dr. Ethan Basch, an oncologist who also does research on health services and drug regulatory policy at the University of North Carolina Comprehensive Cancer Center and the UNC School of Public Health. In a recent editorial in the New England Journal of Medicine, Dr. Basch wrote about a path toward including patient-reported outcomes, such as symptoms, in both labels for cancer drugs and in the published papers of trial outcomes. Dr. Basch is joining us to discuss his own experience with treating cancer patients, why patient-centered research is important, and why this type of information is frequently ignored. - See more at: http://www.cancernetwork.com/podcasts/implementing-patient-centered-outcomes-cancer-trials?GUID=59A6C40A-05D9-4E87-A0FC-1850E2FF60E0&rememberme=1&ts=25102013#sthash.oxrpW8On.dpuf

 

oday we are speaking with Dr. Ethan Basch, an oncologist who also does research on health services and drug regulatory policy at the University of North Carolina Comprehensive Cancer Center and the UNC School of Public Health. In a recent editorial in the New England Journal of Medicine, Dr. Basch wrote about a path toward including patient-reported outcomes, such as symptoms, in both labels for cancer drugs and in the published papers of trial outcomes. Dr. Basch is joining us to discuss his own experience with treating cancer patients, why patient-centered research is important, and why this type of information is frequently ignored. - See more at: http://www.cancernetwork.com/podcasts/implementing-patient-centered-outcomes-cancer-trials?GUID=59A6C40A-05D9-4E87-A0FC-1850E2FF60E0&rememberme=1&ts=25102013#sthash.oxrpW8On.dpuf

oday we are speaking with Dr. Ethan Basch, an oncologist who also does research on health services and drug regulatory policy at the University of North Carolina Comprehensive Cancer Center and the UNC School of Public Health. In a recent editorial in the New England Journal of Medicine, Dr. Basch wrote about a path toward including patient-reported outcomes, such as symptoms, in both labels for cancer drugs and in the published papers of trial outcomes. Dr. Basch is joining us to discuss his own experience with treating cancer patients, why patient-centered research is important, and why this type of information is frequently ignored. - See more at: http://www.cancernetwork.com/podcasts/implementing-patient-centered-outcomes-cancer-trials?GUID=59A6C40A-05D9-4E87-A0FC-1850E2FF60E0&rememberme=1&ts=25102013#sthash.oxrpW8On.dpuf